You May Also Like

Rens Kroes

Why this bicontinental food blogger starts her day with a cold shower

The dark can help you sleep

The secret to better sleep may be restoring your ancestral connection to the dark

Victoria Beckham is launching a skin-care line

You’ll soon be able to slather on serums from a skin-care line by Victoria Beckham

Apothic Wines created cold-brew-infused red wine

Cold-brew-infused red wine is here to give you double the antioxidant buzz

Happy marriage may stave off midlife weight gain

Why having a healthy relationship with a long-term S.O. could stave off midlife obesity

Kelly Ripa on Anna Kaiser's intense abs exercise

Kelly Ripa swears by this abs exercise from Anna Kaiser for a full-body burn

Here’s why Cigna plans to drastically reduce coverage for this opioid

two pills in an open hand Pin It
Photo: @SashaNell via Twenty20

Drug-related death rates in America have been rising faster than ever, partially due to a spike in opioid abuse, according to a report from the The New York Times. Although opioids are a doctor-prescribed class of pain medication, the CDC estimates that more than a whopping 90 Americans die every day from the often illegally obtained drugs. Because abuse has risen so quickly, particularly of OxyContin, health insurance provider Cigna—one of the largest in the nation—will stop covering most prescriptions for it starting January 1, according to CNN.

OxyContin is an opioid painkiller that’s highly addictive due to its higher concentration of active ingredients, making it a black-market prescription drug of choice for many, which ultimately contributes to the national drug crisis in America right now.

Cigna’s solution, though, isn’t to stop treating the pain: Not only will the insurance company still consider distributing OxyContin prescriptions when they’re deemed necessary (which hardly seems like a scientific marker need, BTW), but it will also suggest a different drug—Xtampza ER—which features what CNN calls “abuse-deterrent properties.”

Really addressing the opioid epidemic is “about increasing access to non-opioid treatment for chronic-pain patients.” — Walid Gellad, MD

Whether Xtampza ER will be a sufficient replacement drug is yet to be determined, though. Walid Gellad, MD, and co-director of the University of Pittsburgh’s Center for Pharmaceutical Policy and Prescribing told CNN that Cigna’s new policy doesn’t completely mitigate the chances of addiction or drug abuse. Dr. Gellad also noted that really addressing the opioid epidemic is “about increasing access to non-opioid treatment for chronic-pain patients.”

So, no, Cigna isn’t solving the American opioid epidemic, but it’s certainly taking a first step in the right direction.

Learn more about celebrities, like Lady Gaga, who live with chronic pain. Good news? Meditation can be useful in alleviating it.